The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA...
Benzinga· 7 days agoThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of Enhertu (trastuzumab deruxtecan) and Lynparza (olaparib) for breast ...
UTSW Researchers Develop Rapid COVID-19 Test to Identify Variants in Hours
Newswise· 4 days agoIn just a few hours, UT Southwestern scientists can tell which variant has infected a COVID-19 patient – a critical task that can potentially influence treatment decisions but takes days or ...
Return To The Office? CEOs Learn To Love Remote Workers, For Now
Investor's Business Daily· 3 days agoMeanwhile, recent studies suggest that working from home makes people happier, healthier and even...